Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
Baldi, Salem, He, Yun, Ivanov, Igor, Khamgan, Hassan, Safi, Mohammed, Alradhi, Mohammed, Shopit, Abdullah, Al-Danakh, Abdullah, Al-Nusaif, Murad, Gao, Yaping, Tian, Hui
Published in Frontiers in genetics (14.10.2022)
Published in Frontiers in genetics (14.10.2022)
Get full text
Journal Article
Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma
Baldi, Salem, Khamgan, Hassan, Qian, Yuanyuan, Wu, Han, Zhang, Zhenyu, Zhang, Mengyan, Gao, Yina, Safi, Mohammed, Al-Radhi, Mohammed, Zuo, Yun-Fei
Published in Frontiers in oncology (02.08.2021)
Published in Frontiers in oncology (02.08.2021)
Get full text
Journal Article
ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression
Baldi, Salem, Zhang, Qianshi, Zhang, Zhenyu, Safi, Mohammed, Khamgan, Hassan, Wu, Han, Zhang, Mengyan, Qian, Yuanyuan, Gao, Yina, Shopit, Abdullah, Al‐Danakh, Abdullah, Alradhi, Mohammed, Al‐Nusaif, Murad, Zuo, Yunfei
Published in Journal of cellular and molecular medicine (01.12.2022)
Published in Journal of cellular and molecular medicine (01.12.2022)
Get full text
Journal Article